Matches in Nanopublications for { ?s ?p "[CDA is involved in gemcitabine inactivation, and there is conflicting data on the role of the non-synonymous CDA Lys²⁷Gln polymorphism in predicting toxicity and survival in cancer patients treated with gemcitabine.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- NP383649.RADKPAjOrmkRKL9pRKmLhPG9oC0aNgspgBbUyi7Y3nFso130_assertion description "[CDA is involved in gemcitabine inactivation, and there is conflicting data on the role of the non-synonymous CDA Lys²⁷Gln polymorphism in predicting toxicity and survival in cancer patients treated with gemcitabine.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP383649.RADKPAjOrmkRKL9pRKmLhPG9oC0aNgspgBbUyi7Y3nFso130_provenance.
- NP298293.RAbOCFaUIGByqar3lXLp7cF0BkqyMbZZjYEi8MwiAZCi8130_assertion description "[CDA is involved in gemcitabine inactivation, and there is conflicting data on the role of the non-synonymous CDA Lys²⁷Gln polymorphism in predicting toxicity and survival in cancer patients treated with gemcitabine.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP298293.RAbOCFaUIGByqar3lXLp7cF0BkqyMbZZjYEi8MwiAZCi8130_provenance.
- NP298393.RAKN5XBD3CEXuurBmgE3DqcWstro118Fc8Mys9MCqBaEE130_assertion description "[CDA is involved in gemcitabine inactivation, and there is conflicting data on the role of the non-synonymous CDA Lys²⁷Gln polymorphism in predicting toxicity and survival in cancer patients treated with gemcitabine.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP298393.RAKN5XBD3CEXuurBmgE3DqcWstro118Fc8Mys9MCqBaEE130_provenance.